Review
doi: 10.1046/j.1365-2796.1996.t01-1-379746000.x.
Aplastic anaemia with a trilineage response to erythropoietin therapy
Affiliations
- PMID: 8551205
- DOI: 10.1046/j.1365-2796.1996.t01-1-379746000.x
Item in Clipboard
Review
Aplastic anaemia with a trilineage response to erythropoietin therapy
J Intern Med.
1996 Jan.
Abstract
An 89-year-old man with a severe aplastic anaemia is described. The patient was proven to be cortico-steroid and cyclosporin resistant, but had a trilineage response during subsequent treatment with recombinant human erythropoietin.
Comment in
-
Sustained trilineage response to erythropoietin therapy in a case of aplastic anaemia.J Intern Med. 1997 Nov;242(5):437-9. doi: 10.1046/j.1365-2796.1997.00225.x. J Intern Med. 1997. PMID: 9408076 No abstract available.
Similar articles
-
Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.Eur J Pediatr. 1994 May;153(5):325-7. doi: 10.1007/BF01956411. Eur J Pediatr. 1994. PMID: 7518392
-
Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.Br J Haematol. 1992 Mar;80(3):409-11. doi: 10.1111/j.1365-2141.1992.tb08154.x. Br J Haematol. 1992. PMID: 1374630 No abstract available.
-
Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.Am J Med. 1992 Jul;93(1):41-8. doi: 10.1016/0002-9343(92)90678-5. Am J Med. 1992. PMID: 1626572
-
Mycobacterial disease associated with aplastic anaemia.J Infect. 1989 Sep;19(2):157-65. doi: 10.1016/s0163-4453(89)91964-6. J Infect. 1989. PMID: 2681429 Review.
-
Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.Isr J Med Sci. 1996 Dec;32(12):1201-6. Isr J Med Sci. 1996. PMID: 9007154 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
